FDA approved Vaxelis, a new combination DTaP-IPV-Hib-HepB vaccine for use in children 6 wks-4 yrs of age
On Dec. 26, 2018, Sanofi announced the U.S. Food and Drug Administration (FDA) had approved VAXELIS (Diphtheria and…
Biotechnology | CDC | Disease | Life Science News | Vaccine
ACIP published updated recommendations on use of hepatitis A vaccine for pre- and post-exposure prophylaxis for international travel
On Nov. 2, 2018, the Immunization Practices Advisory Committee (ACIP) published updated recommendations on use of hepatitis A…
Biotechnology | CDC | Disease | Life Science News | Vaccine
CDC published ACIP recommendations for use of hepatitis B vaccine with a novel adjuvant
On Apr. 20, 2018, the Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee (ACIP)…
CDC published updated ACIP recommendations for prevention of hepatitis B virus infection
On Jan. 12, 2018, the U.S. Centers for Disease Control and Prevention (CDC) published updated Immunization Practices Advisory…
FDA licensed Heplisav-B, the new hepatitis B vaccine from Dynavax, for use in adults age 18 and older
On Nov. 9, 2017, the FDA licensed Heplisav-B, the new hepatitis B vaccine, to Berkeley-based Dynavax Technologies for…
CDC published updated dosing instructions for hepatitis A prophylaxis with immune globulin
On Sept. 15, 2017, the U.S. Centers for Disease Control and Prevention (CDC) published updated GamaSTAN S/D prescribing…
AAP issued policy stating that newborns should routinely receive hepatitis B vaccine within 24 hours of birth
On Aug. 28, 2017, the American Academy of Pediatrics (AAP) issued policy stating that newborns should routinely receive…
CDC published the 2017 U.S. recommended adult immunization schedule
On Feb. 10, 2017, the U.S. Centers for Disease Control and Prevention (CDC) published the 2017 U.S. recommended…
Arbutus’ CSO, Dr. Michael J Sofia, awarded Lasker~DeBakey Clinical Medical Research Award
On Sept. 13, 2016, Arbutus Biopharma announced that Dr. Michael J. Sofia, Arbutus’ Chief Scientific Officer, had been…
CDC published guidance for HBV protection and postexposure management of healthcare personnel
On Dec. 20, 2013, the U.S. Centers for Disease Control and Prevention (CDC) published guidance for HBV protection…
ACIP voted to recommend hepatitis A vaccination for close contacts of international adoptees
On Feb. 25, 2009, the Advisory Committee on Immunization Practices (ACIP) recommended routine hepatitis A vaccination for household…
National Quality Forum included the hepatitis B birth dose among its consensus standards
On Oct. 27, 2008, the National Quality Forum included the hepatitis B birth dose among its consensus standards…
CDC published updated recommendations for prevention of hepatitis A virus infection
On Oct. 19, 2007, the U.S. Centers for Disease Control and Prevention (CDC) published updated recommendations for prevention…
Biotechnology | Diagnostics | Infectious Disease | Life Science News | Non-Profit Research | Oncology | Vaccine
National Cancer Institute reported risk of lymphoma increases with Hepatitis C virus infection
On May 8, 2007, the National Cancer Institute (NCI) reported that people infected with the hepatitis C virus…
FDA approved an accelerated dosing schedule for Twinrix (hepatitis A and B vaccine)
On Mar. 28, 2007, the FDA announced that GlaxoSmithKline (King of Prussia, Pennsylvania) received approval for an alternate…
CDC’s ACIP updated immunization strategy to eliminate transmission of Hepatitis B Virus infection in the U.S.
On Dec. 23, 2005, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…
FDA approved lowering the age limit to 12 mos for remaining US-licensed hepatitis A vaccine in the US
On Oct. 17, 2005, the FDA approved lowering the age limit to 12 mos for the remaining U.S.-licensed…
FDA approved lowering the age limit to 12 mos for one of the two licensed hepatitis A vaccine
On Aug. 11, 2005, the Food and Drug Administration (FDA) approved an application of a pediatric/adolescent formulation of…
Vaccine that combined diphtheria, tetanus, acellular pertussis, inactivated polio and hepatitis B antigens was licensed
On Dec. 13, 2002, the U.S. Food and Drug Administration (FDA) announced it had licensed a combined diphtheria…
Genentech drug Pegasys (peginterferon alfa-2a) approved
On Dec. 3, 2002, Genentech drug Pegasys (peginterferon alfa-2a) was approved by the Food and Drug Administration (FDA)…
A combined hepatitis A inactivated and hepatitis B (recombinant) vaccine was licensed
On May 11, 2001, the Food and Drug Administration (FDA) licensed a combined hepatitis A and B vaccine…
FDA approved a 2-dose schedule of hepatitis B vaccination for adolescents
On Aug. 29, 1999, Merck, West Point, Pennsylvania) received approval from the FDA of a supplement to Merck’s…
ACIP recommended DTaP vaccines for all five doses in the vaccination schedule
On Jan. 15. 1999, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…
The Children’s Vaccine Program was established at WHO’s Program for Appropriate Technology in Health (PATH)
On Aug. 26, 1998, the Children’s Vaccine Program was established at WHO’s Program for Appropriate Technology in Health…
Research caused concern that hepatitis B vaccination might be linked with multiple sclerosis
In 1998, some research caused concern that hepatitis B vaccination might be linked with multiple sclerosis (MS), a…
A combined Haemophilus influenzae type b conjugate and hepatitis B vaccine was licensed
On Oct. 2, 1996, the Food and Drug Administration (FDA) licensed a combined Hib conjugate and hepatitis B…
A second inactivated hepatitis A vaccine (Vaqta by Merck) was licensed
On Mar. 29, 1996, the second inactivated hepatitis A vaccine (Vaqta by Merck) was licensed.
The first inactivated hepatitis A vaccine was licensed
On Feb. 22, 1995, the first inactivated hepatitis A vaccine, distributed by SmithKline Beecham Pharmaceuticals (Philadelphia, Pennsylvania), was…
ACIP recommendations for routine hepatitis B vaccination for all infants were published in MMWR
On Nov. 22, 1991, the Immunization Practices Advisory Committee (ACIP) published recommendations for routine hepatitis B vaccination for…
Recombinant hepatitis B vaccine (Engerix-B by SmithKline Beecham) was licensed
On Aug. 28, 1989, a second recombinant hepatitis B vaccine, Engerix-B (SmithKlineBeecham), was approved for use in the…